在胰腺癌中STAT3的作用
Zachary Hamel1, Sierra Sanchez1, David Standing1
1Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Exploration of targeted anti-tumor therapy
|March 11, 2024
概括
信号转换器和转录3激活器 (STAT3) 在胰腺癌的发展和进展中至关重要. 向STAT3为胰腺管腺癌 (PDAC) 提供了一个有前途的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 胰腺癌,特别是胰腺管腺癌 (PDAC),在对其分子驱动因素的不完全理解下,给全球健康带来了重大挑战.
- 信号转换器和转录激活器 (STAT) 家族,特别是STAT3,涉及各种癌症过程,但其在PDAC中的特定作用需要进一步阐明.
研究的目的:
- 总结目前对STAT3在胰腺癌中的作用的理解,重点关注其在癌细胞和瘤微环境 (TME) 中的激活.
- 审查在临床前和临床环境中针对PDAC治疗的STAT3的治疗潜力.
主要方法:
- 关于胰腺癌中STAT3现有研究的综合文献综述.
- 在PDAC细胞和TME中分析STAT3激活机制.
- 在PDAC中评估STAT3向治疗的临床前和临床试验数据.
主要成果:
- 在PDAC瘤发生,进展,免疫逃避,药物耐药性和干性方面,STAT3起着至关重要的作用.
- STAT3信号影响瘤微环境 (TME),影响癌症的整体轨迹.
- 在PDAC中STAT3的重要性可能超过KRAS,突出其治疗意义.
结论:
- 在胰腺管腺癌中,STAT3 是一个关键的分子参与者,影响了该疾病的多个方面.
- 向STAT3是一个非常有吸引力和有前途的治疗途径,用于开发胰腺癌的新疗法.
- 为了改善患者的治疗结果,需要进一步研究STAT3的多方面的作用和治疗向.
相关概念视频
01:20The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:22PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K